Tony Medrano is the CEO and co-founder of LongevityPlan.AI, a platform that combines wearable data, biomarkers, medical records, and lifestyle activity into a personalized “Digital Twin” — an AI-powered software replica of the human body built to predict, optimize, and personalize health, recovery, and performance in real time. Through its proprietary Digital Twin for Predictive Peptide Performance™ technology, LongevityPlan.AI delivers physician- supervised peptide protocols and personalized longevity recommendations to athletes, coaches, businesses, organizations, and government and military clients, with the mission of democratizing NFL- and Ironman-level performance optimization for everyday people.
Before founding LongevityPlan.AI in 2025, Tony built a career at the intersection of law, business, and emerging technology. He is a three-time technology company CEO with two successful exits — including a $1 billion molecular diagnostics company and a mobile app platform company — and co-authored one of the first issued patents for mobile applications, helping shape the early mobile ecosystem before smartphones existed.
He holds degrees from Harvard University and Columbia University, along with a JD/MBA from Stanford University. Tony began his career as a U.S. Navy Officer commanding an emergency response team aboard a USN destroyer, and has since worked with organizations including NASA, the FBI, the U.S. Olympic Team, the NFL, NBA, and MLB.
A three-time full Ironman Triathlon finisher (140.6 miles) who didn’t take endurance sports seriously until he was dared into his first race at age 48, Tony credits daily peptide use with his ability to train four hours a day, five days a week at 55 — an age he calls merely his “chronological age,” citing self-reported metabolic and biological age markers well below it.
He was profiled in a September 2026 Inc. magazine feature, “The Peptide Boom Is Coming for the C-Suite,” which examined how LongevityPlan.AI and a wave of telehealth startups are marketing peptides directly to entrepreneurs and executives, even as most of the compounds remain unapproved by the FDA and stuck in a regulatory gray zone. Tony’s stated goal is to eventually bring peptide therapy into corporate benefits packages alongside things like gym memberships, and LongevityPlan.AI is already pursuing partnerships with enterprise and Fortune 500 clients. His most active online and press content centers on separating evidence from hype in the exploding peptide space (including widely discussed compounds like BPC- 157), GLP-1s, hyperbaric oxygen therapy, and how Digital Twin technology can extend not just lifespan but healthspan.
Links:
Twitter/X: @TMedrano2
—
Get your FREE eBook and Webinar at www.foreverclientformula.com
The Principles of Performance is proud to be recognized by FeedSpot as one of the Top 30 Fitness Podcasts: https://podcast.feedspot.com/fitness_podcasts/
We have also been recognized as one of the Top 100 Strength Coach Podcasts on the web by MillionPodcasts: https://www.millionpodcasts.com/strength-coach-podcasts/
Podcast: Play in new window | Download